CardioComm Solutions, Inc. [CVE: EKG]: Redefining Cardiac Monitoring

Since its inception, CardioComm Solutions, Inc. (“CardioComm”) has been at the forefront of providing innovative remote patient monitoring technologies to enable use of cardiac monitors for recording, transmitting, viewing, and reporting of ECGs. With over 20 years of expertise in supporting hospitals, medical call centers, and doctors’ offices, CardioComm has evolved as a leader in the medical diagnostic industry. Unlike its competitors, the firm holds a unique distinction as an FDA cleared, ISO certified and Health Canada/CE approved company for the development, sale, and marketing of “software as a medical device (SaaMD)” and ECG monitoring devices. Moreover, unlike its competitors, CardioComm owns its own source code allowing the company to apply its proprietary technology to provide novel connectivity and data transmission solutions between patient, device, doctor, and health plan decision makers for diagnosis and ongoing management of patients.

CardioComm’s core technology is its Global ECG Monitoring Solution (GEMS™) software that enables viewing, storing, analyzing, and sharing of ECGs over a global virtual healthcare network. The company provides a total solution for the patient monitoring landscape through a validated software platform that agnostically manages medical device connectivity with different manufacturer’s ECG devices that CardioComm has validated. This total solution platform is HIPAA compliant and provides a fully auditable end-to-end system for use in device, patient/physician communication protocols and for controlling computer or cloud-based systems to run any remote monitoring installation. Cloud resources are controlled by CardioComm in Canada which is compliant with Canadian and U.S. health data storage regulations. With the ability to seamlessly control patient data sharing and storage management in complains with all regulatory and technology standards, CardioComm is helping to drive telemedicine offerings to new levels. The GEMS™ technology can also be integrated within other firm’s service platforms.

As more medical devices like ambulatory ECG monitors and glucometers are widely being adopted in patient care, the assurance of the genuineness of data from such devices remains a point of concern. There are threats that devices can be engineered to alter the raw data collected while recorded, transferred or stored. “We ensure that the software and hardware devices involved in our SaaMD ECG management solutions present a true biological signal.